Showing results (41-50 of 195) with videos related to

Sort By:
Pageof 20
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 1999
Hepatitis E virus infection in travelersE Schwartz, N P Jenks, P Van Damme, et al.
Vaccine|January 1, 1995
Hepatitis B prevention in Europe: a preliminary economic evaluationP Van Damme, G Tormans, P Beutels, et al.
Vaccine|October 31, 1998
Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year resultsK Van Herck, P Van Damme, S Thoelen, et al.
Acta Gastro-Enterologica Belgica|April 8, 1998
Prevention of vertical transmission of hepatitis B virus infection. Is there a standard policy in Flanders (Belgium)?K De Groote, P Van Damme, A Deprettere, et al.
The Journal of Infection|July 25, 2000
The disease burden of hepatitis B in UzbekistanP Beutels, E I Musabaev, P Van Damme, et al.
Scandinavian Journal of Gastroenterology|January 15, 2000
Two-dose combined vaccination against hepatitis A and B in healthy subjects aged 11-18 yearsK Van Herck, P Van Damme, F Collard, et al.
Epidemiology and Infection|February 24, 2005
Prevalence of hepatitis C in drug users in Flanders: determinants and geographic differencesC Matheï, G Robaeys, P van Damme, et al.
Statistics in Medicine|March 17, 2001
Repeated-measures models to evaluate a hepatitis B vaccination programmeD Renard, L Bruckers, G Molenberghs, et al.
Social Science & Medicine (1982)|July 1, 1993
Cost-effectiveness analysis of prenatal screening and vaccination against hepatitis B virus--the case of BelgiumG Tormans, P Van Damme, G Carrin, et al.
Neuro-Degenerative Diseases|August 16, 2006
Excitotoxicity and amyotrophic lateral sclerosisP Van Damme, M Dewil, W Robberecht, et al.
Pageof 20